This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Harbour Biomed (Shanghai) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yunxing Yang - Innovator in Antibody Development
Introduction
Yunxing Yang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. His work focuses on targeting specific proteins that are crucial in cancer therapy.
Latest Patents
Yunxing Yang holds a patent for a CLDN18.2-targeting antibody, which is a bispecific antibody designed for therapeutic use. The invention discloses antibodies that have a high affinity for tumor cells expressing CLDN18.2. This single-domain heavy-chain antibody can induce high endocytic activity, making it a promising candidate for cancer treatment. The bispecific antibody targets both CLDN18.2 and CD3, optimizing the release of common cytokines to reduce adverse effects during treatment.
Career Highlights
Yunxing Yang is currently associated with Harbour Biomed (Shanghai) Co., Ltd., where he continues to advance his research in antibody development. His innovative approach has positioned him as a key figure in the biotechnology sector.
Collaborations
Yunxing collaborates with notable colleagues, including Ming-jin Jheng and Yongqiang Wang, to further enhance the impact of his research and innovations.
Conclusion
Yunxing Yang's contributions to the field of antibody development highlight his role as an influential inventor in biotechnology. His work promises to advance cancer treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile